BRÈVE publiée le 25/04/2024 à 16:30, il y a 2 années 5 mois European Healthcare Acquisition & Growth Company B.V. Releases 2023 Annual Report Financial Statements Investor Relations AGM 2024 EHC Annual Report 2023 European Healthcare Acquisition & Growth Company
COMMUNIQUÉ DE PRESSE publié le 25/04/2024 à 16:25, il y a 2 années 5 mois European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2023 European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2023, including financial statements and the board's report. The report is available for download in ESEF Financial Statements Annual Report 2023 ESEF European Healthcare Acquisition & Growth Company B.V. Board Report
COMMUNIQUÉ DE PRESSE publié le 10/11/2023 à 07:30, il y a 2 années 10 mois EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Expiry and delisting of the Warrants on 17 November 2023
COMMUNIQUÉ DE PRESSE publié le 07/11/2023 à 17:30, il y a 2 années 11 mois EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Results of the Repurchase Offer
COMMUNIQUÉ DE PRESSE publié le 04/10/2023 à 21:30, il y a 3 années EQS-Adhoc: EHC convenes EGM to extend business combination deadline and publishes repurchase document relating to redemption of public shares and proposed amendment of Warrant T&C
COMMUNIQUÉ DE PRESSE publié le 27/09/2023 à 18:30, il y a 3 années European Healthcare Acquisition & Growth Company B.V. publishes its half-year report 2023
COMMUNIQUÉ DE PRESSE publié le 20/09/2023 à 12:30, il y a 3 années EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. announces intention to extend Business Combination Deadline, to offer redemption of Public Shares and to terminate all Public and Sponsor Warrants
COMMUNIQUÉ DE PRESSE publié le 07/08/2023 à 19:00, il y a 3 années 2 mois EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH terminate discussion on business combination
COMMUNIQUÉ DE PRESSE publié le 27/06/2023 à 12:55, il y a 3 années 3 mois General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions
COMMUNIQUÉ DE PRESSE publié le 26/06/2023 à 19:15, il y a 3 années 3 mois EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. removes shareholders’ votes on proposed business combination with Croma-Pharma GmbH from agenda of general meeting
Publié le 09/10/2026 à 19:27, il y a 2 heures 49 minutes Disclosure of transactions in own shares from October 1 to October 9, 2026
Publié le 09/10/2026 à 19:27, il y a 2 heures 49 minutes Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Publié le 09/10/2026 à 17:45, il y a 4 heures 32 minutes Déclaration des droits de vote à fin septembre 2026
Publié le 09/10/2026 à 22:10, il y a 7 minutes Kidoz Inc. to Present at Planet MicroCap Showcase: TORONTO 2026 in Partnership with MicroCapClub on Wednesday, October 28, 2026
Publié le 09/10/2026 à 14:00, il y a 8 heures 17 minutes Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence
Publié le 09/10/2026 à 14:00, il y a 8 heures 17 minutes Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Publié le 09/10/2026 à 13:23, il y a 8 heures 54 minutes SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
Publié le 09/10/2026 à 13:00, il y a 9 heures 17 minutes Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
Publié le 09/10/2026 à 21:24, il y a 52 minutes Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Publié le 09/10/2026 à 21:17, il y a 59 minutes EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Publié le 09/10/2026 à 19:22, il y a 2 heures 54 minutes EQS-Adhoc: elumeo SE switches financial reporting to comply with the German Commercial Code (HGB) and refines forecast for 2026
Publié le 09/10/2026 à 18:00, il y a 4 heures 16 minutes ARVERNE GROUP: Arverne franchit une étape majeure : l'Europe fait du projet Lithium de France un pilier de sa souveraineté industrielle
